Literature DB >> 33595790

Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review.

Saleem Ahmed1, Sjaak Pouwels2, Chetan Parmar3,4, Radwan Kassir5, Maurizio de Luca6, Yitka Graham7,8, Kamal Mahawar7,8.   

Abstract

Obesity is commonly associated with non-alcoholic fatty liver disease and is a significant cause of chronic liver disease and cirrhosis. Some patients undergoing bariatric surgery suffer from cirrhosis of the liver. Currently, there is a lack of consensus on the management of these patients and the safety and efficacy of bariatric surgery in this group. This review aims to update our previously published systematic review on the same topic. A total of 21 studies reporting experience on patients with cirrhosis undergoing bariatric surgery were included. Sleeve gastrectomy was the most common surgery performed, followed by Roux-en-Y gastric bypass. The results show that bariatric surgery may be feasible in carefully selected patients with obesity and cirrhosis although they have slightly higher morbidity and mortality rates.

Entities:  

Keywords:  Bariatric surgery; Child-Pugh classification; Cirrhosis; Metabolic surgery

Mesh:

Year:  2021        PMID: 33595790     DOI: 10.1007/s11695-021-05289-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  5 in total

1.  Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.

Authors:  Annalisa Berzigotti; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Rosa Morillas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Roberto J Groszmann
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

2.  Increased perioperative mortality following bariatric surgery among patients with cirrhosis.

Authors:  Jeffrey D Mosko; Geoffrey C Nguyen
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382

3.  Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience.

Authors:  Laura Pestana; James Swain; Ross Dierkhising; Michael L Kendrick; Patrick S Kamath; Kymberly D Watt
Journal:  Mayo Clin Proc       Date:  2015-02       Impact factor: 7.616

4.  Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates.

Authors:  Matthew Y C Lin; M Mehdi Tavakol; Ankit Sarin; Shadee M Amirkiai; Stanley J Rogers; Jonathan T Carter; Andrew M Posselt
Journal:  Surg Obes Relat Dis       Date:  2013-03-21       Impact factor: 4.734

5.  Morbidly Obese Patients Awaiting Liver Transplantation-Sleeve Gastrectomy: Safety and Efficacy From a Liver Transplant Unit Experience.

Authors:  A García-Sesma; J Calvo; A Manrique; F Cambra; I Justo; O Caso; A Marcacuzco; C Loinaz; C Jiménez
Journal:  Transplant Proc       Date:  2018-06-28       Impact factor: 1.066

  5 in total
  5 in total

Review 1.  Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.

Authors:  Sjaak Pouwels; Nasser Sakran; Yitka Graham; Angela Leal; Tadeja Pintar; Wah Yang; Radwan Kassir; Rishi Singhal; Kamal Mahawar; Dharmanand Ramnarain
Journal:  BMC Endocr Disord       Date:  2022-03-14       Impact factor: 2.763

Review 2.  The use of very low-calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review.

Authors:  Grant J Herrington; Joshua J Peterson; Linhai Cheng; Benjamin M Allington; Renato D Jensen; Heather S Healy; Marcelo L G Correia
Journal:  Obes Sci Pract       Date:  2022-01-22

3.  Fecal Metabolome and Bacterial Composition in Severe Obesity: Impact of Diet and Bariatric Surgery.

Authors:  Nuria Salazar; Manuel Ponce-Alonso; María Garriga; Sergio Sánchez-Carrillo; Ana María Hernández-Barranco; Begoña Redruello; María Fernández; José Ignacio Botella-Carretero; Belén Vega-Piñero; Javier Galeano; Javier Zamora; Manuel Ferrer; Clara G de Los Reyes-Gavilán; Rosa Del Campo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores-An 11.6-Year Follow-Up Study.

Authors:  Elfrid Christine Smith Sandvik; Kristin Matre Aasarød; Gjermund Johnsen; Dag Arne Lihaug Hoff; Bård Kulseng; Åsne Ask Hyldmo; Hallvard Græslie; Siren Nymo; Jorunn Sandvik; Reidar Fossmark
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

Review 5.  Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review.

Authors:  Jacqueline Hoozemans; Maurits de Brauw; Max Nieuwdorp; Victor Gerdes
Journal:  Metabolites       Date:  2021-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.